RxDoctor Payments Data

Michael Swinyard

Pediatric Endocrinology · South Jordan, UTNPI 1245222819

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,334 of the $41,667 with a category attached, or 89.6%. Tandem Diabetes Care, Inc. accounts for 88.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $22,773 and has fallen 98.6% since, to $314 in 2025.

$41,667in general payments, 2019–2025

Across 181 payments — averaging $230.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tandem Diabetes Care, Inc.$37K
  • Dexcom, Inc.$3K
  • Novo Nordisk$434
  • Medtronic$310
  • Sanofi-aventis U.S. LLC$263
  • Insulet Corporation$201
  • plus $588 from 9 others

What the payments were for

  • Speaking & faculty fees$37,33490%
  • Travel & lodging$1,9845%
  • Food & beverage$2,3026%
  • Education$480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric endocrinology providers in Utahto place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium17$120

Paid to pharmacies, not to this prescriber.

Other pediatric endocrinology in South Jordan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →